Contact

All Stories

  1. Defining response to therapy with biologics in severe asthma: from global evaluation to super response and remission

    Article • Expert Review of Respiratory Medicine, June 2023, Taylor & Francis

    Dr Konstantinos Panagiotis Bartziokas

  2. “Extrafine single inhaler triple therapy effect on health status, lung function and adherence in COPD patients: A Panhellenic prospective non-interventional study – The TRIBUNE study”

    Article • Respiratory Medicine, June 2023, Elsevier

    Dr Konstantinos Panagiotis Bartziokas

  3. Cardiovascular Diseases in COPD: From Diagnosis and Prevalence to Therapy

    Article • Life, May 2023, MDPI AG

    Dr Konstantinos Panagiotis Bartziokas, Anastasia Papaporfyriou

  4. Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD Exacerbations

    Article • Journal of Personalized Medicine, April 2023, MDPI AG

    Dr Konstantinos Panagiotis Bartziokas

  5. Global initiative for chronic obstructive lung disease (GOLD) recommendations: strengths and concerns for future needs

    Article • Postgraduate Medicine, October 2022, Taylor & Francis

    Dr Konstantinos Panagiotis Bartziokas, Anastasia Papaporfyriou

  6. IL-26 in the Lung and Its Role in COPD Inflammation

    Article • Journal of Personalized Medicine, October 2022, MDPI AG

    Dr Konstantinos Panagiotis Bartziokas

  7. SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics

    Article • The Journal of Allergy and Clinical Immunology In Practice, October 2022, Elsevier

    Dr Konstantinos Panagiotis Bartziokas

  8. The Diagnostic Role of Uric Acid to Creatinine Ratio for the Identification of Patients with Adverse Pulmonary Embolism Outcomes

    Article • Diagnostics, January 2022, MDPI AG

    Dr Konstantinos Panagiotis Bartziokas

  9. Microalbuminuria on admission for acute exacerbation of COPD as a predictor of all-cause mortality and future exacerbations

    Article • Postgraduate Medical Journal, December 2021, BMJ

    Chris Kyriakopoulos, Dr Konstantinos Panagiotis Bartziokas

  10. Evaluation of the Clinical Effectiveness of the Salmeterol/Fluticasone Fixed-Dose Combination Delivered via the Elpenhaler® Device in Greek Patients with Chronic Obstructive Pulmonary Disease and Comorbidities: The AEOLOS Study

    Article • Journal of Personalized Medicine, November 2021, MDPI AG

    Chris Kyriakopoulos, Dr Konstantinos Panagiotis Bartziokas

  11. The Role of Blood Eosinophils in the Management of COPD: An Attempt to Answer the Important Clinical Questions

    Article • COPD Journal of Chronic Obstructive Pulmonary Disease, October 2021, Taylor & Francis

    Dr Konstantinos Panagiotis Bartziokas

  12. ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations

    Article • European Respiratory Journal, October 2021, European Respiratory Society (ERS)

    Professor Alexandru Corlateanu, Dr Alexander G Mathioudakis, Jørgen Vestbo, Dr Konstantinos Panagiotis Bartziokas

  13. The role of uric acid to creatinine ratio as predictor marker during pulmonary embolism

    Article • September 2021, European Respiratory Society (ERS)

    Dr Konstantinos Panagiotis Bartziokas

  14. The role of Microalbuminuria as a predictor marker during acute exacerbations of Chronic Obstructive Pulmonary Disease

    Article • September 2021, European Respiratory Society (ERS)

    Dr Konstantinos Panagiotis Bartziokas

  15. Blood eosinophils as predictor of outcomes in patients hospitalized for COPD exacerbations: a prospective observational study

    Article • Biomarkers, April 2021, Taylor & Francis

    Dr Konstantinos Panagiotis Bartziokas

  16. Device use errors among patients with asthma and COPD and the role of training: a real-life study

    Article • Postgraduate Medicine, March 2021, Taylor & Francis

    Dr Konstantinos Panagiotis Bartziokas, Anastasia Papaporfyriou

  17. Serum uric acid and arterial lactate levels in patients with obstructive sleep apnea syndrome: the effect of CPAP treatment

    Article • Postgraduate Medicine, January 2021, Taylor & Francis

    Dr Konstantinos Panagiotis Bartziokas

  18. Lactate dehydrogenase, COVID-19 and mortality

    Article • Medicina Clínica, January 2021, Elsevier

    Dr Konstantinos Panagiotis Bartziokas

  19. Lactate dehydrogenase, COVID-19 and mortality

    Article • Medicina Clínica (English Edition), January 2021, Elsevier

    Dr Konstantinos Panagiotis Bartziokas

  20. Identification and treatment of T2-low asthma in the era of biologics

    Article • ERJ Open Research, September 2020, European Respiratory Society (ERS)

    Chris Kyriakopoulos, Dr. Konstantinos Kostikas, Dr Konstantinos Panagiotis Bartziokas

  21. The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): rationale and vision

    Article • European Respiratory Journal, July 2020, European Respiratory Society (ERS)

    Professor Alexandru Corlateanu, Jørgen Vestbo, Dr Konstantinos Panagiotis Bartziokas

  22. Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol

    Article • ERJ Open Research, July 2020, European Respiratory Society (ERS)

    Professor Alexandru Corlateanu, Jørgen Vestbo, Dr Konstantinos Panagiotis Bartziokas

  23. Serum Surfactant Protein Levels in Patients Admitted to the Hospital with Acute COPD Exacerbation

    Article • Lung, February 2018, Springer Science + Business Media

    Dr Konstantinos Panagiotis Bartziokas, Anastasia Papaporfyriou

  24. Serum periostin in patients hospitalized for COPD exacerbations

    Article • Cytokine, May 2017, Elsevier

    Dr Konstantinos Panagiotis Bartziokas, Anastasia Papaporfyriou

  25. Duration of Hospitalization and Lung Function Deterioration as Predictors of Future Chronic Obstructive Pulmonary Disease Exacerbations

    Article • American Journal of Respiratory and Critical Care Medicine, March 2016, American Thoracic Society

    Dr Konstantinos Panagiotis Bartziokas

  26. The Effect of Incidental Consolidation on Management and Outcomes in COPD Exacerbations: Data from the European COPD Audit

    Article • PLoS ONE, July 2015, PLOS

    Dr sylvia hartl, Bernardino Alcazar Navarrete, Ady Angélica Castro-Acosta, Dr Konstantinos Panagiotis Bartziokas

  27. Cardiovascular comorbidities in hospitalised COPD patients: a determinant of future risk?

    Article • European Respiratory Journal, April 2015, European Respiratory Society (ERS)

    Dr. Konstantinos Kostikas, Dr Konstantinos Panagiotis Bartziokas

  28. Prediction of Hospitalization Stay in COPD Exacerbations: The AECOPD-F Score

    Article • Respiratory Care, June 2014, Daedalus Enterprises

    Dr Konstantinos Panagiotis Bartziokas

  29. Collateral Damage: Depressive Symptoms in the Partners of COPD Patients

    Article • Lung, May 2014, Springer Science + Business Media

    Dr Konstantinos Panagiotis Bartziokas

  30. Serum uric acid as a predictor of mortality and future exacerbations of COPD

    Article • European Respiratory Journal, May 2013, European Respiratory Society (ERS)

    Dr Konstantinos Panagiotis Bartziokas

  31. Novel Anti-Inflammatory Agents in COPD: Targeting Lung and Systemic Inflammation

    Article • Current Drug Targets, January 2013, Bentham Science Publishers

    Dr Konstantinos Panagiotis Bartziokas

  32. The impact of depressive symptoms on recovery and outcome of hospitalised COPD exacerbations

    Article • European Respiratory Journal, August 2012, European Respiratory Society (ERS)

    Dr Konstantinos Panagiotis Bartziokas

  33. Statins and outcome after hospitalization for COPD exacerbation: A prospective study

    Article • Pulmonary Pharmacology & Therapeutics, October 2011, Elsevier

    Dr Konstantinos Panagiotis Bartziokas

  34. Vibration Response Imaging: evaluation of rater agreement in healthy subjects and subjects with pneumonia

    Article • BMC Medical Imaging, March 2010, Springer Science + Business Media

    Dr Konstantinos Panagiotis Bartziokas